社区老年COVID-19患者住院与重症结局的相关因素
该研究基于纽约市电子健康记录队列(n=47,219)分析65岁以上社区居住的COVID-19患者,发现随年龄增长,性别、种族、合并症和生物标志物的风险比下降,而痴呆和衰弱风险比不降;无门诊就诊史者住院和重症率更高,最年长组效应最强。
要点
- 社区老年COVID-19患者中,痴呆和衰弱的风险随年龄增长不下降。
- 无门诊就诊史者住院和重症风险显著更高,最年长组效应最强。
- 随年龄增长,性别、种族、合并症和生物标志物的风险比下降。
核心结论
- 在社区居住的老年人中,存在年龄特异性的COVID-19住院和重症风险因素。
- 无门诊就诊史与更高的住院和重症调整率相关,最年长组效应最强。
- 痴呆和衰弱的风险比随年龄增长不下降,而其他因素风险比下降。
研究设计与样本
- 研究为电子健康记录队列,纳入2020年1月至2021年2月纽约市学术医疗机构和公立医院系统中65岁以上实验室确诊COVID-19患者(n=47,219)。
- 暴露因素包括人口学特征、合并症、衰弱和实验室结果,其中有门诊记录者31,770人。
- 主要结局为COVID-19住院、重症结局(ICU、插管、透析、卒中、院内死亡)和院内死亡。
主要发现
- 有门诊病史的31,770例患者中位年龄74岁,47.4%为男性,24.3%为非西班牙裔白人,23.3%为非西班牙裔黑人,18.4%为西班牙裔。
- 随年龄增长,性别、种族、合并症和生物标志物的比值比和归因分数下降,但痴呆和衰弱(医院衰弱风险评分)除外。
- 无门诊就诊史者相比有门诊史者,COVID-19住院和重症结局的调整率显著更高,最年长组效应最强。
临床怎么用
- 对社区居住的老年COVID-19患者,应关注痴呆和衰弱作为持续风险因素。
- 无近期门诊就诊史的老年人可能需更积极评估和干预以降低重症风险。
- 年龄特异性的风险因素可用于识别高危老年患者。
局限性
- 研究为观察性队列,可能受混杂因素影响。
- 未来需探索衰弱和痴呆对社区老年COVID-19重症结局的影响及门诊参与的作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Morbidity and death due to coronavirus disease 2019 (COVID-19) experienced by older adults in nursing homes have been well described, but COVID-19's impact on community-living older adults is less studied. Similarly, the previous ambulatory care experience of such patients has rarely been considered in studies of COVID-19 risks and outcomes. METHODS: To investigate the relationship of advanced age (65+), on risk factors associated with COVID-19 outcomes in community-living elders, we identified an electronic health records cohort of older patients aged 65+ with laboratory-confirmed COVID-19 with and without an ambulatory care visit in the past 24 months (n = 47,219) in the New York City (NYC) academic medical institutions and the NYC public hospital system from January 2020 to February 2021. The main outcomes are COVID-19 hospitalization; severe outcomes/Intensive care unit (ICU), intubation, dialysis, stroke, in-hospital death), and in-hospital death. The exposures include demographic characteristics, and those with ambulatory records, comorbidities, frailty, and laboratory results. RESULTS: The 31,770 patients with an ambulatory history had a median age of 74 years; were 47.4% male, 24.3% non-Hispanic white, 23.3% non-Hispanic black, and 18.4% Hispanic. With increasing age, the odds ratios and attributable fractions of sex, race-ethnicity, comorbidities, and biomarkers decreased except for dementia and frailty (Hospital Frailty Risk Score). Patients without ambulatory care histories, compared to those with, had significantly higher adjusted rates of COVID-19 hospitalization and severe outcomes, with strongest effect in the oldest group. CONCLUSIONS: In this cohort of community-dwelling older adults, we provided evidence of age-specific risk factors for COVID-19 hospitalization and severe outcomes. Future research should explore the impact of frailty and dementia in severe COVID-19 outcomes in community-living older adults, and the role of engagement in ambulatory care in mitigating severe disease.
引用
- Kim J, Blaum C, Ferris R, et al. Factors associated with hospital admission and severe outcomes for older patients with COVID-19. J Am Geriatr Soc. 2022. PMID: 35179781. doi:10.1111/jgs.17718
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。